Ordering
Available Variants5 mg
CHA.37672-5mg
Price
€90.40
Available – Dispatch in 14 days
25 mg
CHA.37672-25mg
Price
€339.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.37672-5mg | €90.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.37672-25mg | €339.20 |
≥98% (HPLC), adenosine A2A antagonist, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H15N7O2 |
|---|---|
| CAS Number | 139180-30-6 |
| Molecular Weight | 337.34 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329831597 |
| NACRES | NA.77 |
| MDL number | MFCD00908394 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
ZM 241385, also known by its CAS number 139180-30-6, is a selective antagonist of the adenosine A2A receptor. This compound has been extensively studied for its potential therapeutic applications, particularly in the treatment of neurological disorders. By blocking the action of adenosine at the A2A receptor, ZM 241385 has been shown to modulate neurotransmitter release and exhibit neuroprotective effects. Its high affinity and selectivity for the A2A receptor make it a valuable tool for investigating the role of adenosine in various physiological and pathological processes. Furthermore, ZM 241385 has been used in numerous preclinical studies to explore its potential as a treatment for conditions such as Parkinsons disease, where modulation of adenosine receptors may provide symptomatic relief. Overall, ZM 241385 is an important compound in the field of adenosine receptor research.
